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Neuroprotective potential of V. teucrium and V. jacquinii methanol extracts was analyzed. Chemical analysis of
investigated extracts showed the presence of phenolic acid derivatives, ﬂavonoids and one secoiridoid. The detected
ﬂavonoids derived from ﬂavones (luteolin and isoscutellarein in V. jacquinii; apigenin, isoscutellarein and luteolin in
V. teucrium) and ﬂavonol (quercetin in V. jacquinii). Acteoside was the dominant compound in V. jacquinii, while
plantamajoside and isoscutellarein 7-O-(6‴-O-acetyl)-b-allosyl (1‴?2‴)-b-glucoside were the major phenolics in
V. teucrium. Additionally, the antineurodegenerative activity was tested at concentrations of 25, 50, and 100 lg/ml
using acetylcholinesterase (AChE) and tyrosinase (TYR) assays. The inhibition of both enzymes was achieved with the
investigated extracts, ranging from 22.78 to 35.40% for AChE and from 9.57 to 16.38% for TYR. There was no
statistical difference between the activities of the analyzed extracts. Our data indicate that V. teucrium and V. jacquinii
may have beneﬁcial effects against Alzheimer’s and Parkinson’s disease.
Keywords: Antineurodegenerative activity, Natural products, Acteoside, Plantamajoside, Antioxidans.
Introduction
Veronica genus (Plantaginaceae) includes around 450
species, which have been used in folk medicine in
Europe and Asia for the treatment of certain problems
of the nervous and respiratory systems, wound heal-
ing, as well as a diuretic.[1] Also, aerial parts of numer-
ous species from genus Veronica are edible, either raw
or cooked. On the other hand, there is absence of sci-
entiﬁc evidence to support their traditional use. A few
studies reported that some of them exhibited notice-
able antioxidant,[2] anti-inﬂammatory,[1][3] and neuro-
protective activity.[4]
Due to the high utilization of oxygen as well as
high content of unsaturated fatty acids, the neurons
are very sensitive to oxidative stress.[5] That is why it
is considered that the oxidative stress is involved in
Alzheimer’s and Parkinson’s diseases as well as other
neurodegenerative diseases. Although the human
body produces enzymes and non-enzyme antioxidants
that usually maintain ROS levels under control, moder-
ate consumption of exogenous dietary antioxidants is
also suggested, especially in neurological diseases, as
mammalian brain has lower levels of endogenous
antioxidants compared to other organs.[6]
Alzheimer’s disease (AD) is a progressive neurological
disease connected with reduction of acetylcholine
(ACh) and butyrylcholine (BCh) levels in cortex and
hippocampus in the brain.[7] Inhibition of cholinester-
ase enzymes, which break down ACh and BCh, could
be a possible therapeutic approach for AD patients.[7]
Parkinson’s disease (PD) is also a progressive
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neurodegenerative disease, connected with dopamine
deﬁciency in the brain. Current treatments include
generally use of L-DOPA and dopamine agonists.[8] On
the other hand, various studies showed that tyrosinase
might be linked with neuromelanin production and
damaged neurons typical in PD, marking tyrosinase
inhibitors as potential drugs.[9]
In this study, the neuroprotective and antioxidant
potentials of Veronica teucrium and V. jacquinii were
investigated while HPLC-DAD/ESI-MS technique was
used for qualitative and quantitative analyses of their
phenolic compounds.
Results and Discussion
HPLC-DAD/ESI-MS Analysis
The characterization of the phenolic compounds was
performed by HPLC-DAD/ESI-MS analysis, and data of
the retention time, kmax, pseudomolecular ion, main
fragment ions in MS2, tentative identiﬁcation and con-
centration of phenolic acid derivatives and ﬂavonoids
are presented in Tables 1 and 2. UV and mass spectra
obtained by HPLC-DAD/ESI-MS analysis showed that
the phenolic composition of these Plantaginaceae spe-
cies was characterized by the presence of phenolic
acid derivatives (p-hydroxybenzoyl and hydroxycin-
namoyl derivatives) and ﬂavonoids in both species,
and also secoiridoids in V. teucrium. The analysis of
the MS2 fragments revealed that in glycosylated
forms, sugars were always O-linked, except for a C-gly-
cosylated ﬂavone in V. teucrium. The detected ﬂavo-
noids derived from ﬂavones (luteolin and
isoscutellarein in V. jacquinii; apigenin, isoscutellarein
and luteolin in V. teucrium) and a ﬂavonol (quercetin
in V. jacquinii). Sugar substituents consisted of glu-
curonides, hexosides, deoxyhexosides, and pentosides,
as deduced from the losses in the MS2 spectra of 176,
162, 146, and 132 Da, respectively.
Hydroxycinnamoyl Derivatives
Various hydroxycinnamoyl derivatives were
observed, especially caffeic acid derivatives, that
were assigned according to their characteristic UV
spectra, showing maximum wavelength around
326 – 334 nm, and to the product ion at m/z 179
([caffeic acid – H]) observed in their MS2 spectra.
Peak 2 in V. teucrium was identiﬁed as 5-O-caffeoyl-
quinic acid by comparison with a standard, and
also due to its MS2 fragmentation pattern as
reported by Clifford et al.[10]
The characteristic fragments at m/z 179, 161 and
135 were observed in peak 3 (pseudomolecular ion
[M – H] at m/z 539) in V. jacquinii, indicating that
this corresponded to a caffeic acid derivative,
although its precise structure could not be elucidated.
Peak 7, in V. jacquinii yielded a pseudomolecular
ion [M – H] at m/z 755. Its fragmentation was initi-
ated by the initial loss of the caffeoyl unit, producing
an ion at m/z 593 ([M – H – 162]), and the further
loss of pentosyl and deoxyhexosyl residues (or both)
resulted in the formation of ions at m/z 461
([M – H – 162 – 132]), 447 ([M – H – 162 – 146])
and 315 ([M – H – 162 – 146 – 132]). This fragmen-
tation pattern ﬁts with that of forsythoside B,[11][12]
compound that was also described in other Plantagi-
naceae.[13] Peak 11, in the same species, presented a
molecular ion at m/z 607, yielding fragments at m/z
461 ([M – H – 146]) and m/z 315 ([M – H – 146
– 146]) interpreted as the successive loss of coumar-
oyl and rhamnosyl moieties. It also presented the
minor fragments at m/z 161 and m/z 135, correspond-
ing to caffeic acid. Considering the data reported by
Sun et al.,[12] and Li et al.,[14] and also the common
presence of phenylethanoid glycosides in Veronica
genus,[15] peak 11 was tentatively identiﬁed as
forsythenside K.
Peak 12 showed a pseudo-molecular ion at m/z
637, producing ions at m/z 491 ([M – H – 146]), m/z
461 ([M – H – 176]) and m/z 315 ([M – H – 176 –
146]), corresponding to the losses of rhamnose, fer-
ulic acid or both, as well as at m/z 193 ([ferulic
acid – H]) and at m/z 175 ([ferulic acid – H – H2O]
)
were also observed. These features coincide with
those of leukoceptoside A, as also described by Amessis-
Ouchemoukh et al.[16]
Peaks 8 in V. jacquinii and 7 in V. teucrium
([M – H] at m/z 623) were identiﬁed as acteoside
(also known as verbascoside) based on the UV spec-
trum and MS2 fragmentation pattern,[11] and previ-
ously reported in other Veronica species.[15] The MS2
fragment ion at m/z 461 could result from the loss of
a caffeoyl moiety ([M – H – 162]), while the weak
ion at m/z 315 was consistent with the additional loss
of a rhamnose unit, whereas ions at m/z 161 and 135
indicated the presence of caffeic acid. Similar charac-
teristics were also observed for peak 8 in V. teucrium
that was tentatively assigned as isoacteoside, taking
into account that it is expected to elute after acteo-
side in RP-HPLC.[11][15] Peaks 5 and 10 in V. teucrium
gave the same pseudomolecular ion [M – H] at m/z
771, as well as the same MS2 fragmentation pattern
with fragments at m/z 609 ([M – H – 162], loss of a
possible caffeoyl/hexosyl moiety), m/z 477
([M – H – 162 – 132], further loss of an additional
pentosyl moiety) and m/z 315 ([M – H – 162 –
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132 – 162], additional loss of a caffeoyl/hexosyl moi-
ety); the last fragment at m/z 161 is characteristic of
the caffeoyl moiety. These characteristics allowed their
identiﬁcation as aragoside and isoaragoside, respec-
tively, compounds previously reported in other Veron-
ica species.[17] A related phenylethanoid glycosylated
derivative lacking the a-arabinopyranosyl unit present
in aragoside was associated with peak 6 ([M – H] at
m/z 639) in the same plant and peak 5 in V. jacquinii.
This compound produced MS2 fragment ions at m/z
477, ([M – H – 162], loss of a caffeoyl/hexosyl moi-
ety), m/z 315 (([M – H – 162 – 162], further caffeoyl/
hexosyl loss), as well as at m/z 179, m/z 161, and m/z
135, as it is common in caffeic acid derivatives. A
compound with similar characteristics was previously
identiﬁed as plantamajoside in Veronica fuhsii FREYN &
SINT.[18]
Flavonoids
Peak 3 in V. teucrium presented a pseudomolecular
ion [M – H] at m/z 593, releasing MS2 fragment ions
corresponding to the loss of 90 and 120 u (m/z at 503
and 473), characteristic of C-hexosyl ﬂavones, and at
m/z 383 and 353 that might correspond to the api-
genin aglycone plus linked sugar residues.[19] Accord-
ing to these characteristics and the fact that no
relevant fragments derived from the loss of complete
hexosyl residues (162 u) were detected, suggesting
the existence of O-linked sugars, the compound was
identiﬁed as apigenin-C-hexoside-C-hexoside.
Peak 12 in V. teucrium was identiﬁed as an api-
genin glucuronide, based on its molecular ion
[M – H] at m/z 445 and the loss of a 176 u fragment,
releasing the corresponding aglycone at m/z 269. The
compound was tentatively identiﬁed as apigenin-7-O-
glucuronide based on the previous observations of
Grayer-Barkmeijer,[20] about the usual presence of such
derivatives in Veronica species.
Peaks 14 in V. jacquinii and 13 in V. teucrium (the
major compound) showed a pseudomolecular ion
[M – H] at m/z 651, releasing MS2 fragments at m/z
609 (–42 u, loss of an acetyl residue), m/z 447
([M – H – 42 – 162], loss of an acetylhexoside) and
at m/z 285 ([M – H – 42 – 162 – 162], further hexo-
syl loss). The observation of another intermediate ion
at m/z 429 ([M – H – 42 – 180]) suggested that
acetyl group was located on the external sugar.[21] The
ion at m/z 285 corresponding to the aglycone together
with the characteristic UV spectra with maxima at 278,
306, and 326 nm were in agreement with those
described for isoscutellarein, a ﬂavone found in the
same genus.[22] Based on the previous NMRTa
b
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identiﬁcation in Veronica species by Albach et al.,[23]
and the fragmentation proﬁle similar to that described
by Pereira et al.,[24] the compound was identiﬁed as
isoscutellarein 7-O-(6‴-O-acetyl)-b-allosyl-(1‴?2‴)-b-glu-
coside. Peak 13 in V. jacquinii, with the same molecular
ion and similar MS2 fragmentation as peak 14, was
assigned as an isomer of this latter. Peak 11 in V. teu-
crium presented also similar UV and mass spectra char-
acteristics, but a molecular weight 42 Da lower,
suggesting the lack of the acetyl group, so that it was
tentatively identiﬁed as isoscutellarein-7-O-allosyl-O-glu-
coside.
Quercetin derivatives were also detected in
V. jacquinii. Peaks 1 and 4 ([M – H] at m/z 625) were
tentatively identiﬁed as quercetin di-hexosides. The
production of fragment ions at m/z 463 ([M – H –
162]) and m/z 301 (([M – H – 162 – 162]) indicated
the alternative loss of each sugar residue suggesting
their location on different positions of the aglycone,
although their precise identity and location could not
be established, so that they were assigned as querce-
tin-O-hexoside-O-hexoside I and II. Peak 9, with a
molecular weight 42 Da greater, was associated to a
quercetin-O-acetylhexoside-O-hexoside, which was
also coherent with its fragmentation proﬁle. One addi-
tional quercetin derivative was detected with the
pseudomolecular ion at m/z 463 (peak 10), which was
positively identiﬁed as quercetin-3-O-glucoside by
comparison with a commercial standard. Finally, peak
6 in V. jacquinii was associated to a luteolin derivative
based on its UV spectrum and the fragment ion
observed at m/z 285. MS2 fragmentation yielded ions
at m/z 489 ([M – H – 134]), m/z 327 ([M – H – 134 –
162]) and m/z 285 ([M – H – 134 – 162 – 42]), sug-
gesting the presence of acetyl and hexosyl residues,
although the precise identity of the compound could
not be established.
Other Phenolic Derivatives
Peak 1 in V. teucrium was positively identiﬁed as pro-
tocatechuic acid by comparing its UV spectrum and
retention time with those of a commercial standard.
Peaks 2 in V. jacquinii and 4 in V. teucrium, with a
pseudomolecular ion at m/z 497, were linked to proto-
catechuic acid derivatives based on their UV spectra
similar to this benzoic acid and the characteristic MS2
fragments observed at m/z 153 ([protocatechuic
acid – H]) and 109 ([protocatechuic acid – H –
CO2]
). Despite some of the fragment ions corre-
sponded to common losses such as hexosyl moieties
(fragments at m/z 335), their precise structures could
not be concluded and remain to be identiﬁed.
Peak 9 in V. teucrium presented a pseudomolecular
ion at m/z 523 and an MS2 fragmentation pattern with
three fragments at m/z 179, 161, and 135 characteris-
tic of caffeic acid derivatives, together with another
product ion at m/z 361 (162 u, possible loss of a
hexosyl moiety). These characteristics are coherent
with the structure of verminoside, consisting of the iri-
doid catalpol linked to caffeic acid. Actually, iridoids
are a type of compounds commonly reported in
Veronica species, and the presence of various catalpol
derivatives in Veronica species, including caffeoyl-cat-
alpol, was already reported by Grayer-Barkmeijer.[25]
Evaluation of Antioxidant Activity
The role of oxidative stress in the pathogenesis of
neurodegenerative diseases has received considerable
attention. Accordingly, our ﬁrst step was evaluating
the antioxidant activity of methanol extracts of V. teu-
crium and V. jacquinii. Three different tests (FRAP,
DPPH, and ABTS), often used to assess the antioxidant
activity of medicinal plants, were applied in our study
(Table 3). The reducing capacity of the extracts may
serve as an important indicator of their antioxidant
potential. The ability of the same extracts to reduce
ferric ions was determined employing FRAP assay. The
methanolic extract of V. teucrium exhibited signiﬁ-
cantly stronger activity than the extract of V. jacquinii
and its activity was similar to the activity of the stan-
dard antioxidant BHA. The free radical scavenging
activity of Veronica extracts was determined using
DPPH and ABTS assays. In the DPPH assay, V. teucrium
extract also showed stronger activity (IC50 = 28.49 lg/
ml) than V. jacquinii extract (IC50 = 37.63 lg/ml),
although both extracts were less active than the stan-
dard antioxidants BHT and BHA. However, in the ABTS
assay, the extract of V. jacquinii showed signiﬁcantly
higher activity than the extract of V. teucrium (1.32 
0.04 mg AAE/g for V. teucrium and 1.98  0.04 mg
AAE/g for V. jacquinii), but still lower activity than BHT
and BHA.
The antioxidant activity of both extract could be
explained by their contents of biologically active com-
pounds. Polyphenols are the most abundant sec-
ondary metabolites in plants, which show strong
protective effect on cellular oxidative damage. They
are also recognized as the most important dietary
antioxidants. The dominant group of phenolic com-
pounds in tested Veronica species were phenyl-
propanoid glycosides. The high radical scavenging
activity of acteoside and plantamajoside was previ-
ously shown,[26] namely in the DPPH assay, with IC50
values = 13.0 and 11.8 lM, respectively, compared
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with of 302 lM for BHT. The high radical scavenging
potential of acteoside and plantamajoside is possibly
due to their orto-dihydroxyphenyl moieties. Within the
ﬂavonoid family, quercetin and its derivatives, highly
present in V. jacquinii, are also potent antioxidants.
They exert antioxidant effects by various mechanisms
(radical scavenging, hydrogen donating, singlet oxy-
gen quenching and metal iron chelating). The biologi-
cal activity of quercetin derivatives strongly depends
on the nature and position of the substituents.[27]
Some quercetin derivatives present in V. jacquinii
showed higher anti-DPPH activity compared to ascor-
bic acid and quercetin (IC50 = 21.6 and 27.5 mM for
isoquercetin and hyperoside, respectively, and 27.8
and 32.2 mM for ascorbic acid and quercetin, respec-
tively).[28] In general, quercetin glycosides showed
smaller reducing capacity in FRAP assay.[29] In this
sense, the differences in the antioxidant activity of
V. teucrium and V. jacquinii methanol extracts could
be associated to the difference in the detected sec-
ondary metabolites and their amounts in the
extracts.
Evaluation of Antineurodegenerative Activity
Alzheimer’s disease (AD) affects memory and other
aspects of human mind and is characterised by the
loss of activities relating to the acetylcholine in the
cerebral cortex. The most widely used treatment
against Alzheimer’s disease is the inhibition of acetyl-
cholinesterase (AChE), the enzyme that hydrolyses
acetylcholine.[30] Most of the AchE inhibitors such
as galanthamine were originally isolated from
plants, indicating that herbal medicines are a good
source for the search of novel AchE inhibitors.[31]
Also, it has been proposed that tyrosinase might
be linked with damaged neurons typical for
another progressive neurological disease, Parkin-
son’s disease, pointing to tyrosinase inhibitors as
potential medications.[9]
In a previous work,[4] our group reported moderate
neuroprotective activity of V. jacquinii and V. teucrium
extracts on human neuroblastoma SH-SY5Y cell line
by increasing cell survival in cells stressed with
sodium nitroprusside and H2O2, compared to the non-
stressed cells. Accordingly, in this study the anti-
neurodegenerative activity of those extracts was
checked more thoroughly by testing them at concen-
trations of 25, 50, and 100 lg/ml using acetyl-
cholinesterase (AChE) and tyrosinase (TYR) assays.
Inhibition of both enzymes was obtained by both
extracts and it ranged from 22.78 to 35.40% for AChE
and from 9.57 to 16.38% for TYR (Table 4). There were
no statistical differences between the activities of the
extracts, but they showed statistically weaker activity
than the standards galanthamine for AChE assay and
kojic acid for TYR assay. Also, a statistically signiﬁcant
difference was noticed among tested concentrations
for the individual extracts. The methanol extract of
V. teucrium showed stronger inhibitory effect at the
highest tested concentrations in both assays. How-
ever, methanolic extracts of V. jacquinii exhibited
Table 3. Antioxidant activities of Veronica teucrium and Veronica jacquinii methanol extracts
Methanol extracts DPPH activity
(IC50 [lg/ml])
ABTS activity
(mg AAE/g)*
FRAP assay
(lmol Fe(II)/g)**
V. teucrium 28.49  0.6a 1.32  0.04a 610.47  32.44ad
V. jacquinii 37.63  0.6b 1.98  0.04b 511.85  21.83b
BHT 17.94  0.1c 2.75  0.02c 445.34  7.77c
BHA 13.37  0.4d 2.82  0.01c 583.72  5.26c
Data are presented as means  SD, n = 3. Sample concentrations: *0.5 mg/ml, **0.1 mg/ml; means with different letters are sig-
niﬁcantly different (P < 0.05).
Table 4. Antineurodegenerative activities of Veronica teucrium and Veronica jacquinii methanol extracts
Concentration [lg/ml] AChE inhibition [%] TYR inhibition [%]
V. teucrium V. jacquinii Galanthamine V. teucrium V. jacquinii Kojic acid
25 22.78  0.70a 32.76  1.50a 42.38  0.74a 9.57  1.03a 32.76  1.50a 35.73  5.46a
50 35.40  3.14b 30.42  1.76a 50.56  0.51b 10.85  0.49a 30.42  1.76a 33.93  3.78a
100 35.12  1.94b 26.58  1.77b 57.11  1.68c 16.38  0.84b 26.58  1.77b 51.81  2.55b
Data are presented as means  SD, n = 3. Means with different letters are signiﬁcantly different (P < 0.05).
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maximum inhibition at the lowest tested concentra-
tions (25 and 50 mg/ml) in AChE assay, while the
activity against TYR was not dose dependent.
As for the antioxidant activity, antineurodegenera-
tive activity of V. teucrium and V. jacquinii methanol
extracts could be attributed to the presence of a vari-
ety of biologically active secondary metabolites. A
number of polyphenols isolated from plants were
identiﬁed as AChE and TYR inhibitors, such as querce-
tin, kaempferol and caffeic acid,[32] which were
detected in higher amounts in V. jacquinii. Moreover,
similar ﬁndings were reported for some iridoids.[33]
Bae et al.,[34] showed that acteoside, which is among
the predominant compounds in both V. teucrium and
V. jacquinii extracts, exhibited effective AchE inhibitory
activity. This phenylpropanoid has been reported to
protect human neuroblastoma SH-SY5Y cells against
Ab cell injury by protecting ROS production and mod-
ulating the apoptotic signal pathway.[35] Also, acteo-
side inhibited the aggregation of Ab42 in a dose
dependent manner.[36] These latter authors also
reported that a catechol moiety in the phenyl-
propanoid glucoside is essential for the exhibited
activity. Therefore, the observed inhibitory activity in
our study could be, at least partially, explained by the
presence of acteoside.
On the other hand, there are no data regarding
neuroprotective activity of other dominant compounds
in V. teucrium, like plantamajoside and isoscutellarein7-
O-(6‴-O-acetyl)-b-allosyl-(1‴?2‴)-b-glucoside, and con-
sequently their activity should be determined in some
further investigation and compared with the activities
of crude extract.
Conclusions
This is the ﬁrst study that reports the in vitro
activity of V. teucrium and V. jacquinii methanol
extracts against enzymes involved in neurodegen-
erative diseases in relation to their metabolites
proﬁle. Obtained data provided evidence that
V. teucrium and V. jacquinii methanol extracts inhi-
bit enzymes connected with progression of AD
and PD and also possess signiﬁcant antioxidant
activity. Such activities could be connected to the
presence of a variety of secondary metabolites; i.e.
ﬂavonoids, iridoids, and phenylpropanoid glyco-
sides. Although activities of the extracts were
weaker than usual standards for those activities,
the results of the present study suggest that
V. teucrium and V. jacquinii could be of interest for
the development of supplements that could man-
age neurodegenerative disorders.
Experimental Section
Plant Material
The aerial ﬂowering parts of V. jacquinii and V. teu-
crium were collected in May 2014 from the mountain
Goc in central Serbia. Plant material was taxonomically
determined and deposited with the Herbarium collec-
tion of the Institute for Medicinal Plants Research “Dr.
Josif Pancic”, Belgrade (voucher specimen numbers
were VG 421 and VG 428 for V. jacquinii and V. teu-
crium, resp.). Plants were air dried and reduced to a
ﬁne powder before extraction procedure.
Chemicals
Methanol, ethanol, distilled water, glacial acetic acid,
hydrochloric acid, and ethyl acetate were purchased
from Zorka Pharma, Sabac (Serbia). HPLC-grade ace-
tonitrile was obtained from Merck KgaA (Darmstadt,
Germany). Formic acid was purchased from Prolabo
(VWR International, France). The phenolic compound
standards (quercetin-3-O-glucoside, kaempferol-3-
O-glucoside, p-hydroxybenzoic acid, caffeic acid,
protocatechuic acid, luteolin-7-O-glucoside, apigenin-
7-O-glucoside, and apigenin-6-O-glucoside) were from
Extrasynthese (Genay, France). Gallic acid, quercetin,
ascorbic acid, 2(3)-tert-butyl-4-hydroxyanisole (BHA),
3,5-di-tert-butyl-4 hydroxytoluene (BHT) 2,2-dyphenyl-
1-picrylhydrazyl (DPPH), 2,2-azino-bis(3-ethylbenzothia-
zoline-6-sulfonic acid) diammonium salt (ABTS),
2,4,6-tripyridyl-s-triazine (TPTZ), Folin–Ciocalteu
reagent, acetylcholinesterase from Electrophorus elec-
tricus (electriceel) (AChE), acetylcholine iodide, galan-
thamine hydrobromide from Lycoris sp., kojic acid,
tyrosinase from mushroom and 3,4-dihydroxy-L-pheny-
lalanine (L-DOPA) were purchased from Sigma Chemi-
cals Co. (USA). All other reagents were of analytical
grade. Water was treated in a Milli-Q water puriﬁcation
system (TGI Pure Water Systems, USA).
Characterization of Phenolic Compounds
Extraction procedure and characterization of phenolic
compounds were based on our previously published
protocol.[15] One gram of powdered plant samples
was extracted by stirring with 30 ml of methanol/
water 80:20 (v/v), at r.t., 150 rpm, for 1 h. After ﬁltra-
tion the residue was re-extracted twice with 30 ml of
methanol/water 80:20 (v/v). The combined extracts
were evaporated at 35 °C (rotary evaporator B€uchi
R-210, Flawil, Switzerland) in order to remove metha-
nol. The aqueous phase was lyophilized and then
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re-dissolved in 20% aqueous methanol to obtain a
ﬁnal concentration of 5 mg/ml and ﬁltered through a
0.22-lm disposable LC ﬁlter disk for high performance
liquid chromatography (HPLC-DAD/MS) analysis. The
extracts were analysed using a Hewlett-Packard 1100
chromatograph (Agilent Technologies) with a quater-
nary pump and a diode array detector (DAD) coupled
to an HP Chem Station (rev. A.05.04) data-processing
station. A Waters Spherisorb S3 ODS-2 C18, 3 lm
(4.6 9 150 mm) column thermostated at 35 °C was
used. The solvents used were: (A) 0.1% formic acid in
water, (B) acetonitrile. The elution gradient established
was isocratic 15% B for 5 min, 15 to 20% B over
5 min, 20 – 25% B over 10 min, 25 – 35% B over
10 min, 35 – 50% for 10 min, and re-equilibration of
the column, using a ﬂow rate of 0.5 ml/min. An injec-
tion volume of 100 ll was used. Double online detec-
tion was carried out in the DAD using 280 and
370 nm as preferred wavelengths and in a mass spectro-
meter (MS) connected to HPLC system via the DAD cell
outlet.
MS detection was performed in an API 3200 Qtrap
(Applied Biosystems, Darmstadt, Germany) equipped
with an ESI source and a triple quadrupole-ion trap
mass analyzer that was controlled by the Analyst 5.1
software. Zero grade air served as the nebulizer gas
(30 psi) and turbo gas for solvent drying (400 °C, 40
psi). Nitrogen served as the curtain (20 psi) and colli-
sion gas (medium). The quadrupols were set at unit
resolution. The ion spray voltage was set at 4500 V
in the negative mode. The MS detector was pro-
grammed to perform a series of two consecutive
modes: enhanced MS (EMS) and enhanced product
ion (EPI) analysis. EMS was employed to record full
scan spectra to obtain an overview of all of the ions
in sample. Settings used were: declustering potential
(DP) 450 V, entrance potential (EP) 6 V, collision
energy (CE) 10 V. Spectra was recorded in negative
ion mode between m/z 100 and 1000. Analysis in EPI
mode was further performed in order to obtain the
fragmentation pattern of the parent ion(s) detected
in the previous experiment using the following
parameters: DP 50 V, EP 6 V, CE 25 V, and colli-
sion energy spread (CES) 0 V. Extraction of phenolic
compounds and their characterization were per-
formed according to the previously published proce-
dure.[15] The extracts were analysed using HPLC-DAD/
ESI-MS technique and Hewlett-Packard 1100 chro-
matograph (Agilent Technologies) coupled to an HP
Chem Station (rev. A.05.04) data-processing station.
MS detection was performed in an API 3200 Qtrap
(Applied Biosystems, Darmstadt, Germany) equipped
with an ESI source and a triple quadrupole-ion trap
mass analyzer that was controlled by the Analyst 5.1
software.
Phenolics present in the samples were character-
ized according to their UV and mass spectra and
retention times compared with commercial standards
when available. For the quantitative analysis of pheno-
lics, calibration curve was constructed for different
standards compounds: caffeic acid, protocatechuic
acid, 5-O-caffeoylquinic acid, quercetin-3-O-glucoside,
luteolin-7-O-glucoside, and apigenin-7-O-glucoside.
Quantiﬁcation was performed based on DAD results,
using 280 nm for phenolic acids and 370 nm for
ﬂavonoid related compounds.
Evaluation of Antioxidant Activity
The Ferric-reducing ability of plasma (FRAP) assay was
determined according to procedure described by Ben-
zie and Strain,[37] with slight modiﬁcations. FRAP
reagent was prepared freshly by mixing sodium acet-
ate buffer (300 mmol/l, pH 3.6), 10 mmol/l TPTZ in
40 mmol/l HCl and FeCl3  6 H2O solution (20 mmol/l),
i.e. in proportion 10:1:1 (v/v/v), resp. Prior to use FRAP
solution was warmed to 37 °C. One hundred ll of test
sample (0.5 mg/ml) were added to 3 ml of working
FRAP reagent and absorbance was recorded after
4 min at 593 nm (JENWAY 6305 UV/VIS spectrophoto-
meter). Blank was prepared with distilled water
instead of extract. Ascorbic acid, BHA, and BHT (con-
centration of 0.1 mg/ml) were used as standards. In
order to construct calibration curve the same proce-
dure was repeated for standard solution of FeSO4 
7 H2O (0.2 – 1.6 mmol/l). FRAP values for samples
were calculated from standard curve equation and
expressed in lmol FeSO4  7 H2O/g dry extract as
average values from three measurements.
Free radical scavenging activity of extracts was
determined using 2,2-dyphenyl-1-picrylhydrazyl
(DPPH) assay as previously reported,[38] with BHA and
BHT used as positive controls. Results are presented
as IC50 value (lg/ml). Stock solutions of dry extracts,
prepared in concentration of 1000 lg/ml (w/v), were
diluted with methanolic solution of DPPH (40 lg/ml)
to adjust the ﬁnal volume of reaction mixture of
2000 ll. Methanol was used as a blank, while metha-
nol with DPPH solution was used as a control. BHA
and BHT were used as positive controls (standards).
Each blank, samples and standards’ absorbances were
measured in triplicate. Absorbance of the reaction
mixture was measured after 30 min in the dark at r.t.
at 517 nm using the JENWAY 6305 UV/VIS spectrophoto-
meter. The decrease of absorption of DPPH radical at
517 nm was calculated using equation:
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Inhibition of DPPH radical ð%Þ ¼ ½ðAC  ASÞ=AC  100
where AC is the absorbance of control (without test
sample) and AS is the absorbance of the test samples
at different concentrations. The concentrations of the
extracts/standard antioxidants providing 50% inhibi-
tion of DPPH radicals (IC50 values, lg/ml) were calcu-
lated from DPPH absorption curve at 517 nm.
The scavenging activity of extracts was evaluated
using ABTS assay using procedure of Miller et al.[39]
Stock ABTS+ solution (7 mM) was prepared 12 – 16 h
before experiment in 2.46 mM potassium-persulfate
and stored in the dark at r.t. Stock ABTS+ solution was
diluted by distilled water to obtain an absorbance of
working solution 0.700  0.020 at 734 nm. 50 ll of
extract (0.5 mg/ml) and/or standard solutions (0.1 mg/
ml) were mixed with 2 ml of working ABTS+ solution
and incubated for 30 min at 30 °C. Absorbance was
recorded at 734 nm using JENWAY 6305 UV/VIS spec-
trophotometer. Distilled water was used as blank. BHA
and BHT dissolved in methanol in concentration
0.1 mg/ml were used as standards. ABTS activity was
calculated from calibration curve for ascorbic acid
(0 – 2 mg/l) and expressed as mg of ascorbic acid
equiv. per gram of dry extract (mg AAE/g). All experi-
mental measurements were carried out in triplicate
and presented as average  standard deviation.
Evaluation of Antineurodegenerative Activity
AChE inhibitory activity assay was performed using
96-well plates according to previous method,[40] with
slight modiﬁcations. The test reaction mixture (S) was
prepared by adding 140 ll of sodium phosphate buf-
fer (0.1M, pH 7.0), 20 ll of DTNB, 20 ll of extract-buf-
fer solution containing 5% DMSO (concentration of
25, 50, and 100 lg/ml) and 20 ll of AChE solution (5
units/ml). Blank (B) did not contain AChE solution. The
mixture without extract was used as the control (C),
while the commercial anticholinesterase alkaloid-type
of drug galanthamine was used as standard. After
incubation (15 min, 25 °C), the reaction was initiated
with the addition of 10 ll of acetylthiocholine iodide
and absorbance was measured at 412 nm using Tecan
Sunrise SN microplate reader equipped by XFluor4
software. Percentage of inhibition of AChE was deter-
mined using the formula [(C – (S – B))/C] 9 100.
Tyrosinase inhibitory activity assay was performed
using 96-well plates according to slightly modiﬁed
spectrophotometric method of Masuda et al.[41]. Sam-
ples and standard compound were dissolved in
sodium phosphate buffer (0.1M, pH 7.0) containing 5%
DMSO, in concentration of 25, 50 and 100 lg/ml. The
wells were designed as: A (containing 120 ll of
sodium buffer and 40 ll of tyrosinase in the same
buffer (46 units/l), B (containing only buffer), C (con-
taining 80 ll of buffer, 40 ll of tyrosinase and 40 ll
of sample) and D (containing 120 ll of buffer and
40 ll of sample). After addition of 40 ll of L-DOPA
and incubation (30 min, 25 °C), absorbance was mea-
sured at 475 nm using Tecan Sunrise SN microplate
reader equipped by XFluor4 software. Percentage of
inhibition of tyrosinase was determined using the for-
mula: [((A – B) – (C – D))/(A – B)] 9 100.
Statistical Analysis
The results were expressed as mean value of three dif-
ferent trials. Differences between the group means
and their signiﬁcance were veriﬁed by one-way
ANOVA using the Software package STATISTICA v.7.0.
The signiﬁcance of differences was evaluated using
Bonferroni’s test and statistical signiﬁcance was set at
P < 0.05.
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